NGS TESTING COST
WORLDWIDE
The cost of NGS testing is navigable in most cases -- but it requires actively engaging coverage and assistance programmes before testing happens, not after the bill arrives.
NGS Coverage by Healthcare System
| System | Coverage | Notes |
|---|---|---|
| US Medicare | Covered for advanced solid tumours (National Coverage Determination) | Applies to FDA-approved companion diagnostic platforms for recurrent/metastatic/advanced cancer |
| US Private Insurance | FDA-approved CDx tests generally covered for approved indications | Prior authorisation required; indication language in the order matters significantly |
| US Uninsured / Underinsured | Patient assistance programmes available from most major labs | Foundation Medicine, Guardant Health, Tempus -- apply before testing begins |
| UK (NHS) | NHS Genomic Medicine Service provides WGS and targeted testing for specific cancer indications | Different pathway and turnaround from commercial US testing |
| Germany / France | National insurance covers molecular testing for approved indications | Coverage for broader comprehensive profiling varies; expanding as targeted therapy options grow |
| Clinical trials | NGS included in trial protocol is covered by sponsor | For trial candidates, this is worth knowing upfront |
Frequently Asked Questions
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Questions About the Cost of NGS Testing for Your Case?
CancerFax helps patients navigate insurance coverage, prior authorisation, and patient assistance programmes for comprehensive genomic profiling.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.